SREBP1 is the downstream transcription factor of SMYD3 that regulates CD47 expression in ccRCC, and CD47 is well characterized as an inhibitory checkpoint target expressed on the surface of cancer cells. Here, SREBF1 is linked to nonpapillary renal cell carcinoma.